Atlas Trials

Cabazitaxel in Patients With Recurrent Ovarian Cancer After Failure of Standard Therapy.

Clinical trial NCT02560337 · COMPLETED

Trial details

NCT number
NCT02560337
Sponsor
Vejle Hospital
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Ovarian Cancer
Start date
2015-09-01
Primary completion
2018-12-05
Enrollment
26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.